XXXX in the elderly: is it different from that in younger age groups?

@entity1 @entity116 @entity1576
Our aims were to itemize the clinical features and the outcome of @entity116 in the elderly, as well as any age and sex differences in its acquisition. Therefore, we compared the demographic and clinical data of 12 elderly (group 1) cases of @entity116 with 69 middle-aged @entity1 (group 2) and 12 @entity1 (group 3) suffering from the same disease. There was no significant difference between the site of entry and incubation period or in the clinical and paraclinical findings among the three groups of @entity1 . @entity1576 was found more commonly in group 1 than in groups 2 and 3 (p = 0.0167 and p = 0.0006, respectively). It was also more common in group 2 than in group 3 (p = 0.0140). A mild form of @entity116 was more often detected in @entity1 than in middle-aged and elderly cases (p = 0.0213 and p = 0.0013, respectively). Severe @entity116 was seen more often in group 1 than in groups 2 and 3 (p = 0.0167 and p = 0.0006, respectively). Despite this, the mortality rate was not statistically different among the three groups of @entity1 . Females were affected much less frequently than males with a female:male ratio of 1:3 in all three age groups. Our results suggest that elderly @entity1 are at higher risk of acquiring a more severe form of @entity116 and the subsequent development of @entity1576 . In addition, the disease is more common in males of all age groups, and age and sex have no apparent effect on the outcome of @entity1 with @entity116 .
